immunity News and Research

RSS

Characterization of the severity of Omicron relative to Delta in England

Researchers assessed the relative risks of hospitalization and death by SARS-CoV-2 Omicron variant compared to those by Delta (B.1.617.2).

8 Feb 2022

SARS-CoV-2 infection-induced antibodies may last more than 20 months

A recent research letter published in the JAMA demonstrated the prevalence and the longevity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in coronavirus disease 2019 (COVID-19) unvaccinated United States (US) adults recovered from the disease in the long term.

7 Feb 2022

Novel, rapid and efficient assay for SARS-CoV-2 neutralizing antibodies

Researchers validate a quick, highly efficient, and automated assay to detect neutralizing antibodies against SARS-CoV-2.

7 Feb 2022

Potential tumor vulnerability may be exploited to improve treatment of neuroblastoma

A Ludwig Cancer Research study has identified a potential vulnerability in neuroblastoma tumors that might be exploited to improve treatment of the aggressive childhood cancer, which accounts for roughly 15% of all deaths from pediatric malignancies.

7 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Study explores omicron-reactive T- and B- cell responses in COVID-19 vaccine recipients

A new study analyzes neutralizing antibodies and T-cell responses targeting the SARS-CoV-2 D614G, as well as some variants of concern.

7 Feb 2022

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

A new article reviewed the innate immune detection and signaling pathways that the host uses against SARS-CoV-2.

7 Feb 2022

USP22 crucial for type III interferon signaling and SARS-CoV-2 infection

In a recent study posted to the bioRxiv* pre-print server, a team of researchers demonstrated that ubiquitin-specific peptidase 22 (USP22) is a crucial regulator of basal interferon (IFN) signaling in native human intestinal epithelial cells (hIECs).

7 Feb 2022

Booster vaccines found to augment T-cell responses to SARS-CoV-2 Omicron

In a recent study published in the latest issue of the journal Cell, a team of researchers evaluated T-cell reactivity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant's spike (S) and non-spike proteins.

6 Feb 2022

Vaccine-induced immunity and prior infection effective in reducing COVID severity in reinfections

A recent study posted to the Research Square* preprint server and under consideration for inclusion in the journal Scientific Reports assessed the epidemiology of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reinfections.

6 Feb 2022

Researchers discover a new function of anti-HIV-1 antibodies

Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures.

6 Feb 2022

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Researchers discuss the impact of mRNA booster immunization on the neutralizing activity against the SARS-CoV-2 Omicron variant in the elderly.

6 Feb 2022

Women, smokers and drinkers more likely to develop taste or smell disorders from COVID

Researchers investigate the relationship between TSD and COVID-19.

6 Feb 2022

Greater neutralizing titers observed in vaccinated individuals with breakthrough Omicron infection

Researchers assess the neutralizing power of plasma samples collected from Omicron convalescent individuals who were either vaccinated or unvaccinated.

6 Feb 2022

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

If close friends and family members who contracted COVID-19 had mild cases and recovered quickly, or if they had an adverse reaction to the vaccine, your brain might convince you that you'd have the same experience.

4 Feb 2022

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, takes a promising step in the direction of developing an HIV vaccine.

4 Feb 2022

immunity News and Research

Characterization of the severity of Omicron relative to Delta in England

SARS-CoV-2 infection-induced antibodies may last more than 20 months

Novel, rapid and efficient assay for SARS-CoV-2 neutralizing antibodies

Potential tumor vulnerability may be exploited to improve treatment of neuroblastoma

Colchicine holds promise to reduce the risk of severe COVID-19

Study explores omicron-reactive T- and B- cell responses in COVID-19 vaccine recipients

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

USP22 crucial for type III interferon signaling and SARS-CoV-2 infection

Booster vaccines found to augment T-cell responses to SARS-CoV-2 Omicron

Vaccine-induced immunity and prior infection effective in reducing COVID severity in reinfections

Researchers discover a new function of anti-HIV-1 antibodies

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Women, smokers and drinkers more likely to develop taste or smell disorders from COVID

Greater neutralizing titers observed in vaccinated individuals with breakthrough Omicron infection

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Exploring the comparative efficacy of booster vaccines against SARS-CoV-2 Omicron and Delta variants

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

Review confirms reduced severity of SARS-CoV-2 Omicron infection

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News